J&J's Hip Verdict Appeal Attacks 'Inflammatory' Rhetoric
Kicking off their appeal of a massive bellwether trial verdict, DePuy Orthopaedics Inc. and parent company Johnson & Johnson have told the Fifth Circuit that five hip-replacement patients' defect claims should...To view the full article, register now.
Already a subscriber? Click here to view full article